Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart failure with preserved ejection fraction: The role of intravascular volumes and body composition in exercise-induced progenitor cell mobilization.

International journal of cardiology. Heart & vasculature·2026
Same author

Effects of exercise mode and intensity on retinal microvascular structure and function in heart failure patients with preserved ejection fraction: a pilot exercise intervention trial.

Journal of vascular research·2026
Same author

Longitudinal Trends and Outcomes in Transcatheter Aortic Valve Implantation: a report from the SwissTAVI Registry.

Cardiovascular intervention and therapeutics·2026
Same author

The Role of Packaged Red Blood Cells Administration on Long-term Outcomes in Patients Who Underwent Transcatheter Aortic Valve Implantation.

The Canadian journal of cardiology·2025
Same author

Drug-coated balloon angioplasty and stenting for coronary artery lesions.

Lancet (London, England)·2025
Same author

Indications for Use of Drug-Coated Balloons in Coronary Intervention: Academic Research Consortium Position Statement.

Journal of the American College of Cardiology·2025

Related Experiment Video

Updated: May 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins: have we found the Holy Grail?

Raban Jeger1, Thomas Dieterle

  • 1University Hospital, Petersgraben 4, CH-4031 Basel, Switzerland. rjeger@uhbs.ch

Swiss Medical Weekly
|February 9, 2012
PubMed
Summary

Statins effectively prevent cardiovascular events in patients with coronary artery disease by targeting risk factors. However, potential side effects necessitate careful consideration during patient treatment.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Pharmacology

Background:

  • Coronary artery disease (CAD) management focuses on primary and secondary prevention.
  • Cardiovascular risk factors are key targets for preventing adverse events.
  • Statins are a cornerstone therapy for reducing cardiovascular risk.

Purpose of the Study:

  • To review the role of statins in preventing cardiovascular events in patients with CAD.
  • To highlight the importance of considering statin-associated side effects in clinical practice.

Main Methods:

  • Literature review of studies on statin efficacy and safety in CAD.
  • Analysis of cardiovascular event prevention data.
  • Evaluation of reported side effect profiles.

Related Experiment Videos

Last Updated: May 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Main Results:

  • Statins demonstrate significant efficacy in preventing cardiovascular events.
  • Established safety profile for statin therapy.
  • Identified relevant side effects associated with statin use.

Conclusions:

  • Statins are crucial for cardiovascular event prevention in CAD.
  • Clinical decisions must balance statin benefits against potential side effects.
  • Individualized patient assessment is essential for optimal statin therapy.